Opioids for neuropathic pain (Q24245218)

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Effects of IV morphine in central pain: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

The effect of opioids on phantom limb pain and cortical reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Oral opioid therapy for chronic peripheral and central neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Buprenorphine in a transdermal therapeutic system--a new option

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Intravenous opioid testing in patients with chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Analgesic effects of dextromethorphan and morphine in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Opioid sensitivity of chronic pain: a patient-controlled analgesia method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Multidose/Observational, Comparative Clinical Analgetic Evaluation of Buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Systemic lidocaine in pain due to peripheral nerve injury and predictors of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Opioid Therapy for Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Clinical characteristics and economic costs of patients with painful neuropathic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

21 January 2018

Chronic neuropathic pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Evidence report on the treatment of pain in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Facts and an open mind should guide clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

What decline in pain intensity is meaningful to patients with acute pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Are opioids effective in relieving neuropathic pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Defining the clinically important difference in pain outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Opioids and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Opioid use in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Evaluation and treatment of central pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Ethical challenges in the management of chronic nonmalignant pain: negotiating through the cloud of doubt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

7 January 2021

Efficacy of analgesics in chronic pain: a series of N-of-1 studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

7 January 2021

An updated interdisciplinary clinical pathway for CRPS: report of an expert panel

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

7 January 2021

A double-blind comparison of meptazinol and placebo in patients with acute and chronic pain presenting to the general practitioner

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

7 January 2021

Double-blind comparison of meptazinol (200 mg) and dextropropoxyphene/paracetamol in a multi-centre, general practice setting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006146

7 January 2021

10.1002/14651858.CD006146

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16856116

1 reference

Consolidated OpenCitations Corpus – April 2017